The new projects will take advantage of the Nordic countries’ unique health data to advance the knowledge base about COVID-19 and have been awarded roughly NOK 53 million in funding.
Nordic Life Science
NOT A SUBSCRIBER? SIGN UP TODAY AND GET THE FULL LIFE SCIENCE PICTURE
ONLY 13 €/MONTH
The COVID-19 pandemic
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and
Researchers at Karolinska Institutet report promising results from an in vitro combination therapy against COVID-19. In a study published in EMBO Molecular Medicine, the researchers show that a combination of
Interim results from the ongoing Phase II/III COV002 trial of AZD1222 in the UK, led by the University of Oxford, demonstrated lower local and systemic reactions in older adults (≥56-69
Pfizer and BioNTech has announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to new research. “We are pleased to report a 71
The days are busy for Sweden’s Mikael Dolsten. As head of Pfizer’s R&D he is at the scientific forefront of the fight against the COVID-19 pandemic. If everything goes well,
NLS News
Elekta has announced that Gustaf Salford has been appointed to the role of President and CEO, effective immediately. Salford has been Acting CEO since early June 2020. Elekta’s Board of
The Research Council has announced that the innovation award goes to founder and scientific director Agnete Fredriksen in Vaccibody. The innovation award will honor research-based innovation. Anne Kjersti Fahlvik, Area
The American FDA has granted Fast Track Designation to the company’s drug candidate, RV001. Fast Track Designation is granted to investigational drugs for expedited review by the FDA, to facilitate
Umeå-based Prediktera has made the list of Europe’s most dynamic Artificial Intelligence (AI) startups. “This increases our visibility and opportunities to find partners, employees and customers in Europe and around
AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the approved indications of unresectable Stage III non-small cell lung
The Swedish biotech company Pila Pharma has announced the decision to list the company. The Initial Public Offering (IPO), aiming for listing of the company’s shares on one of the
Microbiome Dx company Bio-Me and Siolta Therapeutics have entered into a collaboration and marketing agreement. Under the agreement, Siolta will provide both samples and insights into key criteria for Bio-Me
Immunicum has entered into an agreement with Van Herk Investments B.V. to acquire all of the shares in DCprime B.V., a Dutch clinical stage company developing cancer relapse vaccines aimed
Oslo Cancer Cluster (OCC) Innovation Park and Incubator plans to expand by 50 000 m2 in the coming years. The goal is to create an international innovation hub in cancer.
Xbrane Biopharma has successfully carried out a directed share issue of approximately SEK 200 million at a subscription price of SEK 68.50 per share (the “Directed Share Issue”). The subscription
Linn Mandahl is steering the Scandinavian arm of AbbVie, and in times of both internal and external changes, a strong culture as a platform is her key to success. In
Novo Nordisk has entered into a definitive agreement to acquire Emisphere Technologies, a drug delivery company with technologies such as the Eligen SNAC technology, that enable oral formulations of therapeutics.
Capitainer has received the International Organization for Standards (ISO) 13485:2016 certification for its Quality Management System (QMS). ISO 13485 is designed specifically for medical device companies and commonly regarded as
The European drug-discovery contract research organization MercachemSyncom has acquired Admescope, based in Oulu, Finland and Södertälje, Sweden. The acquisition will give MercachemSyncom expanded capabilities for tailor-made in vitro and in
Drug and device development
Kancera is donating a chemical library to the national research infrastructure, Chemical Biology Consortium Sweden (CBCS), at SciLifeLab, in order to support national drug development and the study of disease
Nordic Nanovector has enrolled the final two patients into the second safety cohort of its Phase 1 Archer-1 (LYMRIT 37-07) trial investigating safety and preliminary efficacy of Betalutin (177Lu lilotomab
Xbrane Biopharma has enrolled all the planned 580 patients in to XPLORE – the phase III trial for its biosimilar candidate Xlucane. Top-line data from XPLORE is expected to be
SynAct Pharma has announced that an independent Data Safety Monitoring Board (DSMB) has reviewed unblinded and validated data from part 1 of the company’s Phase 2a study in patients with
Calliditas Therapeutics has announced positive topline results from Part A of the global Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary
Profile
Barbro Ehnbom has successfully promoted women in their careers, not least within life sciences, and she is herself a living example of the changes she has pushed for.
In a new job
The company is moving its production of the GAD65 protein, the active substance in its diabetes vaccine Diamyd, from abroad to Umeå, Sweden. The new unit is around 1,000 square
Alligator Bioscience has appointed Gayle Mills as Chief Business Officer to lead the company’s Business Development activities. Mills will be a member of the executive management team at Alligator Bioscience.
Clara Hellner has been appointed new Chairperson for MedTechLabs. She entered the position as Director for Research and Innovation in Region Stockholm in June this year. Clara Hellner is an
Careers
Nordic Life Science had a chat with last year’s winner of the award Female Leader Engineer, Katarina Atteryd, about the award’s impact on her career and her thoughts on leadership,
Job Listing
- 01
01
-
02
-
03
-
04
Driven by research and a passion for Science, Ferring Pharmaceuticals is a Biopharmaceutical company dedicated to the development of innovative treatments which make a real difference in people’s lives all over the world. Active in the areas of Reproductive Health, Urology, Gastroenterology, Endocrinology and Orthopedics’, Ferring Pharmaceuticals develop medicine on the body’s own terms. Ferring […]
Read the latest issue of our magazine!
No 04 2020 // This issue includes an exclusive interview with Evelina Vågesjö, co-founder and CEO of Ilya Pharma, who turned her thesis project into a successful company. Nordic venture capitalists share their perspectives and advice when it comes to raising capital and we take a closer look at the life science industry in Philadelphia, US, where cell and gene therapy is fast becoming a local specialty.
You may also learn more about having a career within clinical research and what to consider when the Medical Device Directive is replaced by the Medical Device Regulation. Scientists in Finland have found a new piece in the Parkinson’s puzzle and SwedenBIO shares their thoughts on how we can secure the right expertise in the future.
The Nobel Prize 2019
Sir Peter J. Ratcliffe defined a system involved in inflammation, metabolism, cancer, and more. On 7 October 2019, Sir Peter J. Ratcliffe was having a typical scientist’s day, writing a
Since nothing is more basic to life than oxygen, Dr. Gregg Semenza, MD, PhD, found it logical to want to unravel some of the complexities of how cells monitor and
William Kaelin feels he has been fortunate in his scientific career. His contributions have had a great impact, not least within cancer treatment, and for future generations he emphasizes the
“It’s so satisfying that we described oxygen sensing that has been around since animal evolution. That’s a discovery for all time, so we’re just rejoicing in that.” – Sir Peter Ratcliffe
Upcoming events
This event is a place for academia-industry collaborations to get started. BioFIT states it operates as a platform to build partnerships for all public and private actors. BioFIT is also the
Biotech Showcase is an investor and partnering conference devoted to providing private and small and mid-cap biotechnology companies an opportunity to present and meet investors and biopharmaceutical executives during the
The goal of the Cancer Crosslinks meetings is to promote interactions between researchers and clinicians, as well as to encourage translational and clinical research, and new collaborations to advance the
NLSDays is the largest Nordic partnering conference dedicated to the life science industry. The 2020 event has been postponed until the 2021 event, April 20-23 2021, delivered digitally. Since its
Our region is filled with life science activity. We take a closer look at what´s going on in our Nordic cities when it comes to life science efforts, progress and challenges.
In focus – Nordic cities
Nordic Life Science
The latest clinical trials
Nordic Nanovector has enrolled the final two patients into the second safety cohort of its Phase 1 Archer-1 (LYMRIT 37-07) trial investigating safety and preliminary efficacy of Betalutin (177Lu lilotomab
Xbrane Biopharma has enrolled all the planned 580 patients in to XPLORE – the phase III trial for its biosimilar candidate Xlucane. Top-line data from XPLORE is expected to be
SynAct Pharma has announced that an independent Data Safety Monitoring Board (DSMB) has reviewed unblinded and validated data from part 1 of the company’s Phase 2a study in patients with
Calliditas Therapeutics has announced positive topline results from Part A of the global Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary
The new projects will take advantage of the Nordic countries’ unique health data to advance the knowledge base about COVID-19 and have been awarded roughly NOK 53 million in funding.
Hansa Biopharma has announced positive data from an investigator-initiated phase 2 trial that evaluated safety, tolerability and efficacy of imlifidase in 15 patients with severe anti-GBM antibody disease. Anti-GBM antibody
Kancera is donating a chemical library to the national research infrastructure, Chemical Biology Consortium Sweden (CBCS), at SciLifeLab, in order to support national drug development and the study of disease
The company has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with the NEFERTITI clinical study of its lead product, pHyph, a vaginal tablet
Nanoform will, in the fourth quarter of 2020, start the first ever human trial of a drug candidate nanoformed using its CESS technology. Dosing will begin before year-end 2020 (previously:
The latest research news from the Nordic region
Science Article
The Novo Nordisk Foundation has awarded a grant of DKK 84.5 million to continue the BRIDGE – Translational Excellence Programme at the University of Copenhagen. The purpose of BRIDGE is to
The Swedish Society of Medicine (SSM) has decided to award the Pasteur medal to Professor Didier Pittet, director of the Infection Control Programme at the Geneva University Hospitals and Faculty
The Tobias Foundation grant in 2020 has been awarded to Magnus Tobiasson and Eva Hellström Lindberg, Karolinska Institutet. The grant amounts to SEK 10 million over a five-year period. It
The Royal Swedish Academy of Sciences has decided to award this year’s Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for
The Nobel Assembly at Karolinska Institutet has decided to award the 2020 Nobel Prize in Physiology or Medicine jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice, for
Women vaccinated against HPV have a significantly lower risk of developing cervical cancer, and the positive effect is most pronounced for women vaccinated at a young age, according to a
Sign up to our newsletter